NR3C2 and hydrops fetalis: Whereas β-blocker was more frequently prescribed in the DOAC group, the use frequencies of antiplatelet and conventional drugs for HF, including angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, and mineralocorticoid receptor antagonist were not markedly different between the two groups.